Health-care companies rose amid deal activity and demand for defensive issues.

Signify Health rose a session after drug-store chain and insurer CVS Health agreed to buy the home-healthcare company for about $8 billion.

Clarus Therapeutics, the maker of testosterone drug Jatenzo, filed for chapter 11 bankruptcy, saying it has missed its sales targets and been unable to meet its debt obligations.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

09-06-22 1708ET